What does CUSIP 45779A853 represent in this 13F holders report?

CUSIP 45779A853 is the security identifier for NSPR - INSPIREMD INC - COM used to aggregate holder disclosures.

How many institutions held NSPR - INSPIREMD INC - COM in Q3 2023?

1 institutional investor reported NSPR - INSPIREMD INC - COM for Q3 2023. Use the holders table for investor-level position and value details.

INSPIREMD INC - COM (NSPR)

CUSIP: 45779A853

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / COM
Total 13F shares: 4
Total 13F value: $13
Share change: 0
SEC-reported price per share: $3.25
Number of holders: 1

Security key

45779A853

Report period

Q3 2023

Institutions

Top holders

NSPR full security history Ownership snapshot Full 13F holder table InspireMD, Inc. SEC filings InspireMD, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NSPR - INSPIREMD INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MARSHALL WACE, LLP

Disclosed value leader

MARSHALL WACE, LLP

Comparable rows

0/15

Latest evidence

30 Jun 2023

13F 3/4/5 Highest disclosed value: $4,669,617 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

MARSHALL WACE, LLP has the largest disclosed position value at $4.67M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MARSHALL WACE, LLP's linked filing trail.

Disclosed position value Top 5

MARSHALL WACE, LLP $4.67M

Nantahala Capital Management, LLC $4.67M

ORBIMED ADVISORS LLC $4.67M

Soleus Capital Management, L.P. $3.46M

Velan Capital Investment Manageme... $2.27M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MARSHALL WACE, LLP	13F Company 13F	— denominator unverified	$4,669,617 1,860,405 shares	—	30 Jun 2023
Nantahala Capital Management, LLC	13F Company 13F	— denominator unverified	$4,669,617 1,860,405 shares	—	30 Jun 2023
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$4,669,617 1,860,405 shares	—	30 Jun 2023
Soleus Capital Management, L.P.	13F Company 13F	— denominator unverified	$3,459,101 1,378,128 shares	—	30 Jun 2023
Velan Capital Investment Management LP	13F Company 13F	— denominator unverified	$2,269,113 904,029 shares	—	30 Jun 2023
PURA VIDA INVESTMENTS, LLC	13F Company 13F	— denominator unverified	$139,757 55,680 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %